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Introduction. The purpose of this paper is to 
review the endocrinologic evaluation of 58 patients 
who presented to our institution this past year with a 
chief complaint of absent or irregular menses. The 
primary goal for presenting these patients is to review 
the results of several newer studies as well as older 
and more classical studies which are useful in the 
differential diagnosis of amenorrhea. Such newer 
studies not only take advantage of the more current 
knowledge of the ovulatory process but also utilize 
recently developed and highly sensitive techniques or 
hormonal assay. It is hoped that this will provide the 
reader with some suggestions for a current and 
efficient method to evaluate the several causes or 
amenorrhea. 
Materials and Methods. Amenorrhea is usually 
categorized as being either primary or secondary. and 
the patient's age or duration of absent menses varies 
among the several definitions available. For the pur­
pose of this paper the following definitions will be 
utilized: 
Primary Amenorrhea. Failure to have initiated 
menstrual bleeding by age 18. 
Secondary Amenorrhea. Cessation of previously 
established menses for an interval of more than one 
year. 
0/igomenorrhea. Spontaneous, irregular menses 
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occurring at intervals of not less than three months. 
Fifty-eight patients were studied and were divid­
ed into three major diagnostic categories according to 
their presenting menstrual patterns. Eight patients 
had primary amenorrhea, forty-six had secondary 
amenorrhea. and four patients had oligomenorrhea. 
Other patients with demonstrable uterine causes of 
amenorrhea are excluded from this study. This in­
cluded patients with Asherman's syndrome, miil­
lerian abnormalities in which no uterus was pres­
ent. and testicular-feminization patients. Thus, all 
patients included had uteri capable of normal 
menstruation, and this was evidenced by proges­
terone-induced withdrawal bleeding, endometrial bi­
opsy, estrogen-progesterone withdrawal bleeding, 
and/or hysterosalpingogram. Patients with easily diag­
nosable abnormalities of thyroid or adrenal function 
also are not included, as early outpatient studies usually 
revealed the etiology of their amenorrhea and ap­
propriate therapy resulted in prompt return of menstrual 
function. For these reasons one can not draw valid 
incidence frequencies from this referral-practice popula­
tion of 58 amenorrheic patients. 
S1udies Performed. All 58 patients were 
hospitalized on the Clinical Research Ward of our 
institution and underwent study. Tests included 
a thorough general and endocrine history, com­
plete physical and pelvic examination, Papanicolaou 
smear. vaginal cytologic maturation index. complete 
blood count. urinalysis. Chem- I 8. anteroposterior 
(AP) and lateral skull x-rays. chest x-ray. and visual 
fields by perimeter. 
All 58 patients also underwent a series or 
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baseline and dynamic hormonal testing. Serum total 
estrogen (I). progesterone (2), follicle stimulating 
hormone (FSH) (3). luteinizing hormone (LH) (4), 
I and growth hormone (5) were all performed in 
duplicate by standard radioimmunoassay techniques. 
Serum prolactin was initially done in the labora­
tory or Dr. Henry Friesen and later by Dr. Stuart 
Handwerger, both using radioimmunoassay (6). 
Serum T, and T3 Uptake were done by standard 
techniques, as were urinary 17-hydroxycorlicoids and 
17-ketosteroids. 
All patients also underwent the following three 
dynamic tests of pituitary function: 
I. Hypoglycemia was induced by the intra­
venous administration of 0.1 units insulin per 
kilogram with blood glucose and human growth hor­
mone (radioimmunoassay) determined at intervals 
over 90 minutes. Blood glucose had to achieve at least 
50% reduction from fasting levels to be considered an 
adequate stimulus for the release of growth hormone. 
A positive growth hormone response to insulin­
induced hypoglycemia consisted of a peak value or 
growth hormone greater than IO ng/ml (7). 
2. Control 24-hour urine collections were ob­
tained for 17-hydroxycorticoids ( 170H) and 17-
ketosteroids ( I 7KS). If normal hydroxycorticoids 
were present. the patient was then given 
Metopirone". 750 mg orally every 4 hours for 6 
doses. After the last dose of Metopirone•. another 
24-hour urine collection was made. A normal re­
sponse of pituitary ACTH was considered present 
if the levels of 17-hydroxycorticoids doubled (8). 
3. The ability to release gonadotropins was 
tested with LH-FSH Releasing Hormone. Baseline 
FSH and LH were determined. then the patients 
received 100 µg SC of A Y 24031, Ayerst Labora­
tories LH-FSH Releasing Hormone. Blood samples 
were then taken at frequent intervals over a period 
of 6 hours, and duplicate samples were assayed by 
radioimmunoassay for FSH and LH. Serum total 
estrogens were determined by radioimmunoassay on 
the control and 6-hours samples. Currently we are 
evaluating a variety of response parameters. and we 
realize that our own criteria for a positive response 
may be altered. However, in the interim. a positive 
response to LH-FSH Releasing Hormone was con­
sidered present if both serum LH rose by more than 
fourfold over baseline and serum FSH at least 
doubled (9). 
Other Studies. As patients were evaluated by the 
techniques listed previously, many were found to 
have significant abnormalities which required further 
investigation. Such studies included: 
Patients with prolactin excess (on duplicate 
samples) usually underwent further testing of prolac­
tin kinetics with L-dopa, chlorpromazine, water load, 
and other studies. If the excess secretion was not 
readily explainable. then sella turcica tomography 
and pneumoencephalography were usually per­
formed. 
Evidence or clinical androgen excess or signifi­
cant laboratory documentation of this usually led to 
determination of serum testosterone, urinary 
pregnanetriol. and appropriate dexamethasone sup­
pression. If an ovarian source was presumed, then 
laparoscopy and ovarian biopsy were carried out. 
Elevated 17-hydroxycorticoids led to the deter­
mination of plasma cortisol and dexamethasone sup­
pression. with pituitary evaluation if pituitary tumor 
was suspected. 
Abnormal thyroid function was evaluated by 
traditional methodology. 
Patients who had stigmata of gonadal dysgene­
sis. or primary amenorrhea which seemed of gonadal 
origin (such as evidenced by elevated gonadotropins), 
were then evaluated by buccal smear and karyotype 
of peripheral leukocytes. If there was evidence or 
signif-icant early estrogen production or a "Y" 
chromosome on karyotype. then laparoscopy and 
gonadal biopsy with both histopathologic study and 
gonadal karyotype were done. Gonads with "Y" 
chromosome were surgically removed. 
If patients had abnormal skull x-rays or signifi­
cant endocrinologic evidence of hypopituitarism or 
pituitary tumor. then tomograms of the sella turcica, 
pneumoencephalography. and/or carotid arteriography 
were performed. 
Once a diagnosis was achieved. appropriate 
therapy was carried out. No patient suffered any 
significant side effects from any of these diagnostic 
studies. 
Results. After these 58 patients had completed 
the previously listed diagnostic studies. a final 
diagnosis was assigned. The tables which follow 
(Tables I. 2. 3) are each arranged with patients 
grouped by these final diagnoses and the results 
of the various diagnostic tests listed below. In this 
fashion one can not only study the results of the 
several tests performed in patients with a particular 
cause of amenorrhea but also evaluate how a specific 
test may provide useful data in the several groups of 
patient diagnoses. 
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TABLE I 
Primary Amenorrhea 
( 8 Patients) 
Constitutional Hypothalamic ?Congcnit..tl Gonadal 
Diagnosis Delay Cause Abscncc LH Dysgenesis 
(No.) (3) (2) (2) (I) 
Family Hx. + -
Estrogen I J sl. I I 
FSH-LH FSH-Normal FSH-Normal FSH-Normal 
LH-sl. I LH-sl. I LH-sl. I II 
HGH. Prolactin. 
170H. 17KS. - - - -
Thyroid 
LRH Test FSH + FSH + FSH + FSH + 
LH + LH + LH - LH + 
lnsulin-HGH + 
Metopironek + 
+ positive response. or normal test result. 
- negative response. or reduced test result. 
(See lex! for details.) 
Primary Amenorrhea (Table I). Eight patients 
presented with primary amenorrhea. Three patients 
were felt to have constitutional delay of menarche. 
Family history was positive in all three patients, and. 
while all had had a sequential development of secon­
dary sex characteristics. all had reduced estrogen 
levels. Levels of FSH were normal and LH levels 
were minimally elevated in all three patients. Baseline 
testing of other hormones was normal. There was a 
significant response in all patients to LH Releas­
ing Hormone, Insulin-Growth Hormone, and Met­
opirone®. The patients' ages were 18, 19, and 23 
years. All have subsequently begun spontaneous 
menses. 
Similar findings to those mentioned in the 
previous category were present in the testing of two 
patients thought to have "hypothalamic" primary 
amenorrhea. except there was no family history of 
delayed menarche. 
Two patients had low baseline serum LH and 
failed to elevate LH in response to LH-Releasing 
Hormone on either of two occasions. This suggested 
lo us a reduced ability to produce, or release, or a 
congenital diminution in LH. 
Finally, one patient had Turner's syndrome 
(gonadal dysgenesis) which was proven by karyotype. 
Serum FSH was quite high, but there still existed a 
capacity of the pituitary to increase gonadotropin 
release when LH-Releasing Hormone was given. 
+ 
+ 
+ + 
+ + 
Secondary Amenorrhea-Organic (Table 2). Six­
teen patients presented with secondary amenorrhea 
which was finally shown to be of an organic etiology. 
Four patients had pituitary tumors; one, a 
patient with a microadenoma and hyperprolac­
tinemia. one with clinical signs of acromegaly. Three 
of the four patients had abnormal skull x-rays and 
reduced estrogen production. Two patients had 
significantly low gonadotropin values. Baseline hor­
monal testing revealed an elevation of growth hor­
mone in the patient with acromegaly. Other baseline 
testing was normal. Two of the four patients failed to 
have an adequate response by LH (one borderline, 
however) while two had a positive response of FSH 
to LH-Releasing Hormone. One of the four patients 
had a negative growth hormone test. All had surgical­
ly proven lesions. 
Two patients had craniopharyngiomas. Both 
had positive skull x-rays and decreased estrogen and 
gonadotropins. One patient had reduced baseline 17-
hydroxycorticoids. One patient had a modest 
response to LH-Releasing Hormone while the other 
had no response. Neither patient responded to 
lnsulin-HGH testing. Metopirone® testing was not 
done in one patient. but ACTH testing was normal. 
Two patients had the "empty sella" syndrome. 
Again. skull x-rays were abnormal in both patients 
and estrogen and gonadotropins were low. Other 
baseline hormonal testing was normal. Both patients 
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responded to Insulin-HG H and Metopirone' '. but 
one patient responded poorly to LH-Releasing 
Hormone. Both patients had this diagnosis con­
firmed by pneumoencephalography. 
Two patients had Sheehan's syndrome with 
postpartum pituitary necrosis. One patient was 
clinically panhypopituitary. finding conf-irmed by low 
test results of estrogen, gonadotropins. thyroid, and 
adrenal function. Neither patient responded positive­
ly with both LH and FSH to LH-Releasing Hormone 
or Insulin-HGH. Metopirone• testing was not per­
formed when low serum cortisols were detected. 
Adrenal response to ACTH was normal. 
Four patients had clinical signs of androgen ex­
cess with significant hirsutism. Clinical estrogeniza­
tion was good in all four. but, while ba:;eline FSH 
was normal, the baseline LH was mildly elevated in 
all. Laboratory evidence of excess androgen was pres­
ent in all four patients and was reflected by elevated 
17-ketosteroids. Serum testosterone was elevated in 
two patients with Stein-Leventhal syndrome. and 
pregnanetriols were elevated in the other two patients 
who were felt to have adult-onset adrenogenital syn­
drome. In all four patients there was a normal 
response of FSH to LH-Releasing Hormone, but an 
impaired LH response. Other testing was normal. 
There were l wo other patients with organic 
causes of secondary amenorrhea, one with 
hypothyroidism and one with premature ovarian 
failure. Test n::sults are as listed. 
Secondary A 111enorrhea-Functional (Table 3 ). 
Thirty patients had secondary amenorrhea which was 
felt to be of functional etiology. Patients are divided 
into diagnoses of anorexia nervosa (4 patients) and 
"hypothalamic" causes (26 patients). This latter large 
group is subdivided into patients who had rapid 
weight loss or gain. stable weight. or had developed 
amenorrhea after utilizing oral contraceptives. Skull 
x-rays and physical examinations were negative ex­
cept for that of weight change. and for four patients 
who had galactorrhea. 
All patients with anorexia nervosa and 
hypoestrogenism had decreased gonadotropins. 
Thyroid function was reduced slightly in two 
TABLE 2 
Secondarv Amenorrhea-Organic 0
( 16 Patients) 
PituitcJry Cranio- ""Empty . . Shct!han·:-. Androgen 
Diagnosis Tumor pharyngioma Sella s� ndrvtllt! Exct:ss 
(No.) (4) (2) (2) (2) (4) 
P. Exam Acromegaly V. Fields ( 11 - Hvpopit. (I) Hirsutism (4) 
(I) 
Galactorrhea 
(I) 
Skull x-ray +(3) + + -
Estrogen I (31 I ! I 
FSH-LH ! (2) I Normal I FSH Normal 
LH I (4) 
HGH. Pro- HGHJ (II 170HJ (II Normal 170H It Ii J 17KS (41 
lactin, 170H. Pro lac- Thyroid J ( 11 J Tcstos. (2) 
I 7KS. Thyroid tin j ( 11 j !'Trio! (21 
LRH Test FSH +2 -(I) sl. I (II - FSH+ 
LH +2 LH-
lnsulin-HGH (Ii + (II + 
M e1opi rone� + - + - + 
Others: 
Hypothyroid ( 1 )-Galactorrhea: decreased estrogen. FSH. LH. thyroid :-.llldic�. 
Other testing normal. 
Prem..iture Ovarian Failure ( I )-Decreased estrogen: elevated �SH and LH. 
Other testing normal. 
+ positive response. or normal test result. 
- negative response. or reduced test result. 
(Sec text for details.) 
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TABLE 3 
Secondary Amenorrhea-Functional 
( 30 Patients) 
Anorexia 
"HYPOTHALAMIC CAUSES" (26) 
Diagnosis Nervosa Rapid wgt. Rapid wgt. Stable wgt. 
"Post Pill" Group Total 
(No.) (4) Loss(4) Gain (3) ( 15) 
(4) (26) 
Skull x-ray - - Galactorrhea 
Galactorrhea 
P. Exam (.l) (I) 
(4) 
Estrogen ! j(I) Normal (4) (2) J (7) 
FSH-LH J J (3) J (2) ,l.j (2) J (2) 
sLJ (2) 
J (7) 
HGH. Pro- Thyroid sl. Normal Normal Thyroid sl. Prolactin Thyroid! (3) 
lactin. 170H. l (2) 
17KS. thyroid 
LRH Test -(3) -(3) 
lnsulin-HGH + -(I) 
Metopirone" + + 
+ positive response. or normal test result. 
- negative response. or reduced test result. 
patients. Three of the four patients failed lo respond 
to LH-Releasing Hormone, but all patients had nor­
mal responses lo insulin by growth hormone and to 
Metopirone•. 
The four patients with rapid weight loss. but not 
anorexia nervosa. showed better estrogenization. but 
low gonadotropins also. Similar poor responsiveness 
to LH-Releasing Hormone was present. 
A greater percentage of patients who had rapid 
weight gain had normal estrogenization. baseline 
gonadotropins. and normal LH-Releasing Hormone 
response. 
Patients with stable weight who were felt lo have 
hypothalamic amenorrhea were basically normal in 
estrogenization and baseline gonadotropins. All 
patients had at least some response lo LH-Releasing 
Hormone, and five had excessive responses. Patients 
who developed amenorrhea after using oral con­
traceptives were similar. 
The 26 patients with hypothalamic amenorrhea, 
as a group, were better estrogenized, had more nor­
mal gonadotropins, and responded more normally or 
excessively to LH-Releasing Hormone than did <he 
patients with anorexia nervosa or patients with 
organic causes of secondary amenorrhea. 
0/igomenorrhea. Four patients had oligo­
menorrhea, two with evidence of ovarian androgen 
excess. Baseline estrogen, gonadotropins, and 
l (3) 1(1) Prolactin I (I) 
-(IJ I +(5) (IJ ++(5) 
+ 
+ 
sl.J (6) sl.j(IJ sl. J (7) 
- (5) 
+ + (I) 
+ + + 
other hormone testing were normal except for one 
patient who was hypothyroid and two hirsute 
patients in whom there were elevated 17-ketosteroids 
and serum testosterone. All four patients had positive 
responses to LH-Releasing Hormone. although in 
two of these patients the response of LH was 
borderline. All patients had normal responses to 
lnsulin-HGH and Metopirone®. 
Summary of Studies. In an attempt to summarize 
these diagnostic studies, one can draw the following 
conclusions from this group of 58 amenorrheic 
women: 
Skull x-rays are very useful, if positive. 
Physical examination is useful when obvious 
signs of endocrinopathy are present, including 
acromegaly. hypopituitarism. galactorrhea. or signs 
of androgen excess. Negative findings do not exclude 
significant organic pathology, however. Findings 
suggesting deficiency of a "target gland" (for 
example, adrenal, thyroid) may be reflections of 
pituitary-hypothalamic dysfunction rather than peri­
pheral gland abnormality. 
Patients with organic causes of amenorrhea are 
more likely lo have clinical hypoestrogenism. and it 
will lend lo be more severe than in patients with 
"functional" or nonorganic causes. The exception is 
anorexia nervosa. certainly a severe functional dis­
order. 
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FI
G
UR E I 
AMENORRHEA 
OUTPATIENT EVALUATION 
Thyroid 
Adrenal 
H,. Physical and Pelvic Exams 
Maturation Index 
Endometrial Biopsy 
CBC. Urinalysis. Chem. 
Skull ,-ray 
170H. 17KS 
FSH 
Thyroid T,. T, 
Progesterone;: Tcsl 
Visual Fields 
Andrugcn 
1-a i lclJ 
Ovary 
l l l 
SUSPECTED 
HYPOPtTUlTARISM 
Baseline serum FSH is of use in identifying 
gonadal failure. or dysgenesis. when FSH is very 
high. 1 n problems of androgen excess and functional 
causes of primary amenorrhea. LH seems likely to be: 
slightly elevated with FSH normal. Gonadotropins 
are low in patients both with central organic causes 
and with the more severe functional causes of this 
problem. 
Baseline measurements of growth hormone. 
prolactin. 17-hydroxycorticoids and 17-ketosteroids. 
and thyroid hormone all are of great use if ab­
normal, but usually will require further evaluation. 
Testing with LH-Releasing Hormone does 
provide useful information. Patients with organic 
causes of amenorrhea, other than gonadal failure or 
androgen excess. were more likely to respond poorly 
to LH-Releasing Hormone: however. a signiticant 
proportion of these patients showed some response: 
with regard to LH, or FSH, or both gonadotropins. 
Patients with functional disorders more likely had 
normal or excessive response to LH-Releasing Hor­
mone while those classified as having more severe 
functional disorders responded very poorly. Growth 
hormone testing with insulin and Metopirone® test­
ing were of relatively little diagnostic aid unless a 
major organic etiology was present; an etiology 
likely demonstrable on skull x-rays. clinical ex­
amination. or in patients with more severe ab­
normalities in baseline hormonal testing. 
We would again emphasize that these are only 
!rends in the results of diagnostic studies in patients 
who present with amenorrhea. Larger group studies 
are needed to evaluate the full statistical significance 
of these data. We would also again emphasize the 
need for a thoughtful. individualized. sequential 
evaluation of each patient who presents. 
Comment. To reach the goal of individualization 
in the evaluation of the amenorrheic patient we 
suggest several possibilities: 
Figure I illustrates what we consider an ade­
quate screening study for the amenorrheic patient 
which usually can be done in the outpatient setting. 
Based on these results. and the clinical tindings pres­
ent. one can categorize problems under thyroid, 
adrenal. ovarian androgen. or gonadal failure for 
further studies which can usually be done in the out-
I'
G
T
E
i 
SUSPECTED HYPOPITUITARISM 
l l l 
INPATIENT STUDY 
Baseline: FSH, LH. Prolactin. Estrogen. Growth Hormone 
Metopirune" Test (") 
Insulin-Induced Hypoglycemia Growth Hormone Test('') 
LH-Releasing Hormone Test (A Y 24031) 
l l l 
"SUSPICIOUS" 
"Fundiunal" 
Follow-up 
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.. SUSPICIOUS" HYPOPITUITARISl\1 
l l l 
2ND INPATIENT STUDY 
If Prolactin-L-Dopa test: Chlorprom,.11inc tc:-.l. \Vatc.:r load 
Pneu moenceph�1 log ram 
Carotid Arteriogram 
THERAPY 
(Medical. Surgical. Irradiation) 
patient setting. Some 
hypopituitarism and 
further study. 
patients will have suspected 
require hospitalization for 
Patients with the problem of suspected hypo­
pituitarism should undergo further testing (Fig. 
2) as evidenced by the preliminary studies. which 
should at least include baseline hormonal testing and 
testing with LH-Releasing Hormone. Growth hor­
mone testing with insulin and/or Metopirone" 
testing may be indicated. but this must be individ­
ualized. Patients who are felt to have "functional" 
disorders causing amenorrhea are begun on appro­
priate therapy or follow-up, while patients who are 
strongly suspected of hypopituitarism usually are 
studied further. 
Further studies (Fig. 3) include tests such as 
prolactin kinetics. pneumoencephalogram. and 
possibly arteriogram. If pituitary tumor. cranio­
pharygioma. or other etiology of hypopituitarism is 
found. then appropriate medical. surgical. or irradia­
tional therapy is initiated. 
In this fashion we have tried to present to you 
the summation of data in 58 patients who presented 
with amenorrhea. and the endocrinologic testing 
results that have led to the <::stablishment of a 
diagnosis. Again. it should be stressed that a 
systematic. individualized work-up is mandatory for 
the adequate endocrinologic work-up of the 
amenorrheic patient. 
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